Recognizing and Treating Ocular Rosacea in Darker Skin Tones - Summary - MDSpire

Recognizing and Treating Ocular Rosacea in Darker Skin Tones

  • By

  • Sarah Fackler, managing editor, Optometric Management

  • January 1, 2026

  • 4 min

Share

Objective:

To address the recognition and treatment of ocular rosacea in patients with darker skin tones, highlighting the differences in presentation and treatment protocols, particularly regarding safety and efficacy.

Key Findings:
  • Ocular rosacea is underrecognized in darker skin tones due to subtle presentation, impacting treatment efficacy.
  • Common manifestations include eyelid telangiectasia, postinflammatory hyperpigmentation, and minimal visible redness, which complicate diagnosis.
  • IPL combined with meibomian gland expression yields superior results compared to either treatment alone, highlighting the need for tailored approaches.
Interpretation:

The findings underscore the importance of tailored treatment approaches and increased education for healthcare providers regarding ocular rosacea in darker skin tones.

Limitations:
  • Lack of representation of darker skin tones in epidemiologic studies and clinical trials.
  • Potential for underdiagnosis due to subtle clinical signs.
  • Need for more diverse clinical trials to improve treatment protocols.
Conclusion:

Customized treatment protocols and increased awareness among healthcare providers are essential for effectively managing ocular rosacea in patients with darker skin tones.

Original Source(s)

Related Content